prednisone has been researched along with Carcinoma in 76 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On the basis of this small retrospective survey, we conclude that CMFVP combination chemotherapy is both effective and safe in patients with metastatic breast cancer previously treated with both taxanes and anthracyclines." | 7.78 | Efficacy of the CMFVP regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane. ( Grenader, T, 2012) |
| " They were then assigned at random to receive no further therapy (NT), ovarian irradiation (R) 2000 rads in 5 days, or ovarian irradiation in the same dosage plus prednisone (R + P) 7." | 6.68 | Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Bulbrook, RD; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Hayward, JL; Jenkin, RD; Meakin, JW; Panzarella, T; Pringle, JF; Rider, WD, 1996) |
| "A selected case file of 32 patients with carcinoma of the lung which had passed the stage of surgical cure was randomized in 3 arms and treated with different schedules: regimen A, adriamycin plus cyclophosphamide; regimen B, the BACON combination, slightly modified; regimen CVP, cyclophosphamide plus vincristine plus prednisone." | 5.04 | Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial. ( Arosio, A; Burdick, L; Cunietti, E; Eridani, S; Maggio, L; Periti, M; Perrone, G, 1978) |
| "On the basis of this small retrospective survey, we conclude that CMFVP combination chemotherapy is both effective and safe in patients with metastatic breast cancer previously treated with both taxanes and anthracyclines." | 3.78 | Efficacy of the CMFVP regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane. ( Grenader, T, 2012) |
| "The national Prostatic Cancer Project has evaluated single and combination chemotherapeutic agents for the treatment of patients with advanced prostatic cancer that has been unresponsive to hormonal therapy." | 3.75 | Chemotherapy of hormonally unresponsive prostatic carcinoma. ( deKernion, JB; Lindner, A, 1984) |
| "Three hundred thirty-six patients with stage II or stage III breast cancer were treated on an adjuvant protocol containing fluorouracil, doxorubicin, cyclophosphamide, vincristine, and prednisone (FACVP)." | 3.67 | Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma. ( Ang, PT; Buzdar, AU; Hortobagyi, GN; Kau, S; Smith, TL, 1989) |
| "Described is a patient with early breast carcinoma who developed clinical radiation pneumonitis during primary radiation therapy and concomitant chemotherapy that included prednisone." | 3.67 | Radiation pneumonitis: a complication resulting from combined radiation and chemotherapy for early breast cancer. ( Catane, R; Gez, E; Isacson, R; Sulkes, A; Weshler, Z, 1985) |
| "Chemotherapy was administered until disease progression or unacceptable toxicity." | 2.76 | Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study. ( Barbanti, G; Bargagli, G; Chiriacò, G; Conca, R; De Rubertis, G; Fiaschi, AI; Francini, E; Francini, G; Manganelli, A; Pascucci, A; Petrioli, R; Ponchietti, R, 2011) |
| " They were then assigned at random to receive no further therapy (NT), ovarian irradiation (R) 2000 rads in 5 days, or ovarian irradiation in the same dosage plus prednisone (R + P) 7." | 2.68 | Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Bulbrook, RD; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Hayward, JL; Jenkin, RD; Meakin, JW; Panzarella, T; Pringle, JF; Rider, WD, 1996) |
| "Burkitt lymphoma is a fast-growing high grade B-cell neoplasm that rarely affects adults." | 2.50 | Adult abdominal Burkitt lymphoma with isolated peritoneal involvement. ( Catarino, R; Estevão, A; Matos, H; Oliveira, C; Serra, P, 2014) |
| "Virilizing adrenal carcinoma is a rare disease, especially in women of reproductive age." | 2.39 | Virilizing adrenal carcinoma in a woman of reproductive age: a case presentation and literature review. ( Coonrod, DV; Rizkallah, TH, 1995) |
| "We report a case of metastatic papillary thyroid carcinoma and undifferentiated nonkeratinizing nasopharyngeal carcinoma to the same cervical lymph node following chemotherapy for mantle cell lymphoma." | 1.42 | Case report: metastases from thyroid and nasopharyngeal carcinomas in the same lymph node following chemotherapy for mantle cell lymphoma. ( Joshua Liao, D; Luo, D; Wang, Z; Xiao, H, 2015) |
| "Reports of bronchiolitis obliterans organizing pneumonia (BOOP) occurring in women after radiation therapy for breast cancer have suggested that radiation to the lung could participate in the development of BOOP." | 1.30 | Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P) ( Cordier, JF; Crestani, B; Dalphin, JC; Roden, S; Valeyre, D; Wallaert, B, 1998) |
| "All cases with lymphadenitis were still alive at the end of the study, while survival progressively decreased in the Hodgkin's type." | 1.30 | Survival of patients with HTLV-I-associated lymph node lesions. ( Haraoka, S; Kanda, M; Kawasaki, C; Kikuchi, M; Ohshima, K; Sato, K; Simazaki, T; Suzumiya, J, 1999) |
| "Two patients developed breast cancer after treatment of Hodgkin's disease." | 1.27 | Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. ( Anderson, T; Cox, JD; Gillin, M; Greenberg, M; Janjan, NA; Schewe, K; Wilson, JF, 1988) |
| "Cases of disintegrating pulmonary metastases are presented." | 1.26 | [Confluent pulmonary deposits from carcinoma of the breast under cytostatic therapy (author's transl)]. ( Blechschmidt, CM; Schermuly, W, 1976) |
| "A group of patients with metastatic breast cancer treated by a distinct drug regimen is analyzed with special respect to clinical and psychological problems." | 1.26 | [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)]. ( Fernholz, HJ; Frik, W; Nüvemann, M, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (63.16) | 18.7374 |
| 1990's | 10 (13.16) | 18.2507 |
| 2000's | 5 (6.58) | 29.6817 |
| 2010's | 13 (17.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohlmann, CH | 1 |
| Miller, K | 1 |
| Gschwend, J | 1 |
| Wang, Z | 1 |
| Luo, D | 1 |
| Xiao, H | 1 |
| Joshua Liao, D | 1 |
| Fan, H | 1 |
| Lu, X | 1 |
| Wang, X | 1 |
| Liu, Y | 1 |
| Guo, B | 1 |
| Zhang, Y | 2 |
| Zhang, W | 1 |
| Nie, J | 1 |
| Feng, K | 1 |
| Chen, M | 1 |
| Wang, Y | 1 |
| Shi, F | 1 |
| Fu, X | 1 |
| Zhu, H | 1 |
| Han, W | 1 |
| Oliveira, C | 1 |
| Matos, H | 1 |
| Serra, P | 1 |
| Catarino, R | 1 |
| Estevão, A | 1 |
| He, JM | 1 |
| Pang, XL | 1 |
| Liang, HJ | 1 |
| de Bono, JS | 2 |
| Smith, MR | 1 |
| Saad, F | 1 |
| Rathkopf, DE | 1 |
| Mulders, PFA | 1 |
| Small, EJ | 1 |
| Shore, ND | 1 |
| Fizazi, K | 2 |
| De Porre, P | 1 |
| Kheoh, T | 1 |
| Li, J | 1 |
| Todd, MB | 1 |
| Ryan, CJ | 1 |
| Flaig, TW | 1 |
| Balachandran, I | 1 |
| Walker, JW | 1 |
| Broman, J | 1 |
| Kim, SJ | 1 |
| Toma, HS | 1 |
| Thirkill, CE | 1 |
| Dunn, JP | 1 |
| Petrioli, R | 1 |
| Pascucci, A | 1 |
| Conca, R | 1 |
| Chiriacò, G | 1 |
| Francini, E | 1 |
| Bargagli, G | 1 |
| Fiaschi, AI | 1 |
| Manganelli, A | 1 |
| De Rubertis, G | 1 |
| Barbanti, G | 1 |
| Ponchietti, R | 1 |
| Francini, G | 1 |
| Flechon, A | 1 |
| Heidenreich, A | 1 |
| Voog, E | 1 |
| Davis, NB | 1 |
| Qi, M | 1 |
| Bandekar, R | 1 |
| Vermeulen, JT | 1 |
| Cornfeld, M | 1 |
| Hudes, GR | 1 |
| Grenader, T | 1 |
| Xu, XF | 1 |
| Zhang, XJ | 1 |
| Montanari, M | 1 |
| Fabbri, F | 1 |
| Rondini, E | 1 |
| Frassineti, GL | 1 |
| Mattioli, R | 1 |
| Carloni, S | 1 |
| Scarpi, E | 1 |
| Zoli, W | 1 |
| Amadori, D | 1 |
| Cruciani, G | 1 |
| Yalin, Y | 1 |
| Pingzhang, T | 1 |
| Smith, GI | 1 |
| Ilankovan, V | 1 |
| WITTEKIND, D | 1 |
| SESSNER, HH | 1 |
| BRINKLEY, DM | 1 |
| PILLERS, EK | 1 |
| ELEY, A | 1 |
| RIDDELL, V | 1 |
| LAMBERG, BA | 1 |
| PELKONEN, R | 1 |
| FRICK, MH | 1 |
| EVANS, FJ | 1 |
| HILTON, JH | 1 |
| MANNHEIMER, IH | 1 |
| RODMAN, T | 1 |
| KARR, S | 1 |
| CLOSE, HP | 1 |
| Loehrer, PJ | 1 |
| Wang, W | 1 |
| Johnson, DH | 1 |
| Aisner, SC | 1 |
| Ettinger, DS | 1 |
| Green, LD | 1 |
| Mack, L | 1 |
| Pasieka, JL | 1 |
| deKernion, JB | 1 |
| Lindner, A | 1 |
| Stephens, RB | 1 |
| Abeloff, MD | 1 |
| Mellits, ED | 1 |
| Baker, RR | 1 |
| Bellone, JD | 1 |
| Kunicki, TJ | 1 |
| Aster, RH | 1 |
| Jacquillat, C | 1 |
| Auclerc, G | 1 |
| Weil, M | 1 |
| Auclerc, MF | 1 |
| Maral, J | 1 |
| Guthrie, TH | 1 |
| Thornton, RM | 1 |
| Marincek, B | 1 |
| Young, SW | 1 |
| Muller, HH | 1 |
| Enzmann, DR | 1 |
| Coonrod, DV | 1 |
| Rizkallah, TH | 1 |
| Lucon, AM | 1 |
| Pompeo, AC | 1 |
| Rodrigues, PR | 1 |
| Mitre, AI | 1 |
| Saldanha, LB | 1 |
| Arap, S | 1 |
| Meakin, JW | 2 |
| Hayward, JL | 1 |
| Panzarella, T | 1 |
| Allt, WE | 1 |
| Beale, FA | 1 |
| Bulbrook, RD | 1 |
| Bush, RS | 1 |
| Clark, RM | 1 |
| Fitzpatrick, PJ | 1 |
| Hawkins, NV | 1 |
| Jenkin, RD | 1 |
| Pringle, JF | 1 |
| Rider, WD | 1 |
| Uthman, I | 1 |
| Vázquez-Abad, D | 1 |
| Senécal, JL | 1 |
| Pinder, SE | 1 |
| Murray, S | 1 |
| Ellis, IO | 1 |
| Trihia, H | 1 |
| Elston, CW | 1 |
| Gelber, RD | 1 |
| Goldhirsch, A | 1 |
| Lindtner, J | 1 |
| Cortés-Funes, H | 1 |
| Simoncini, E | 1 |
| Byrne, MJ | 1 |
| Golouh, R | 1 |
| Rudenstam, CM | 1 |
| Castiglione-Gertsch, M | 1 |
| Gusterson, BA | 1 |
| Crestani, B | 1 |
| Valeyre, D | 1 |
| Roden, S | 1 |
| Wallaert, B | 1 |
| Dalphin, JC | 1 |
| Cordier, JF | 1 |
| Kuper-Hommel, MJ | 1 |
| Vrints, LW | 1 |
| Coebergh, JW | 1 |
| Vreugdenhil, G | 1 |
| Ohshima, K | 1 |
| Suzumiya, J | 1 |
| Sato, K | 1 |
| Kanda, M | 1 |
| Simazaki, T | 1 |
| Kawasaki, C | 1 |
| Haraoka, S | 1 |
| Kikuchi, M | 1 |
| Uthman, IW | 1 |
| Bizri, AR | 1 |
| Khalifeh, MJ | 1 |
| Creager, AJ | 1 |
| Geisinger, KR | 1 |
| Bergman, S | 1 |
| Rogers, AI | 1 |
| Eridani, S | 1 |
| Burdick, L | 1 |
| Maggio, L | 1 |
| Cunietti, E | 1 |
| Periti, M | 1 |
| Arosio, A | 1 |
| Perrone, G | 1 |
| Blechschmidt, CM | 1 |
| Schermuly, W | 1 |
| Nüvemann, M | 1 |
| Fernholz, HJ | 1 |
| Frik, W | 1 |
| Melosky, B | 1 |
| Karim, M | 1 |
| Chui, A | 1 |
| McBride, M | 1 |
| Cameron, EC | 1 |
| Yeung, CK | 1 |
| Landsberg, D | 1 |
| Shackleton, C | 1 |
| Keown, PA | 1 |
| Koh, EH | 1 |
| Buzdar, AU | 3 |
| Ames, FC | 1 |
| Singletary, SE | 2 |
| McNeese, MD | 2 |
| Frye, D | 1 |
| Holmes, FA | 1 |
| Fraschini, G | 1 |
| Hug, V | 1 |
| Theriault, RL | 1 |
| Wright, JC | 1 |
| Thoms, WW | 1 |
| Fletcher, GH | 1 |
| Oswald, MJ | 1 |
| Schoen, HD | 1 |
| Wendt, T | 1 |
| Ang, PT | 1 |
| Smith, TL | 1 |
| Kau, S | 1 |
| Hortobagyi, GN | 1 |
| Janjan, NA | 1 |
| Wilson, JF | 1 |
| Gillin, M | 1 |
| Anderson, T | 1 |
| Greenberg, M | 1 |
| Schewe, K | 1 |
| Cox, JD | 1 |
| Gez, E | 1 |
| Sulkes, A | 1 |
| Isacson, R | 1 |
| Catane, R | 1 |
| Weshler, Z | 1 |
| Haugen, OA | 1 |
| Schell, HW | 1 |
| Cressy, NL | 1 |
| Malaviya, AN | 1 |
| Many, A | 1 |
| Schwartz, RS | 1 |
| Li, MC | 1 |
| Hsu, KP | 1 |
| Byland, W | 1 |
| Nagel, G | 1 |
| Senn, HJ | 2 |
| Jungi, WF | 1 |
| Mayr, AC | 1 |
| Smith, P | 1 |
| Nagel, GA | 1 |
| Carter, SK | 1 |
| Buckle, R | 1 |
| Spigel, SC | 1 |
| Coltman, CA | 1 |
| Costanzi, JJ | 1 |
| Vasavada, PJ | 1 |
| Bournigal, LJ | 1 |
| Reynolds, RW | 1 |
| Lewinsky, BS | 1 |
| Grigor, KM | 1 |
| Symington, T | 1 |
| Neville, AM | 1 |
| Fossa, SD | 1 |
| Billund, JK | 1 |
| Goldfinger, D | 1 |
| McGinniss, MH | 1 |
| Lleander, VC | 1 |
| Goldstein, G | 1 |
| Horsley, JS | 1 |
| Henkin, RI | 1 |
| Bradley, DF | 1 |
| Brun, F | 1 |
| Brunner, KW | 1 |
| Khan, MH | 1 |
| Martin, H | 1 |
| Bardana, EJ | 1 |
| Pirofsky, B | 1 |
| Muggia, FM | 1 |
| Heinemann, HO | 1 |
| Fierer, JA | 1 |
| Wagner, BM | 1 |
| Strebel, RF | 1 |
| Laugier, P | 1 |
| Risold, JC | 1 |
| Ellena, V | 1 |
| Péquégnot, F | 1 |
| Barale, T | 1 |
| Ogunlesi, TO | 1 |
| Kreiger, AE | 1 |
| Meyer, D | 1 |
| Smith, TR | 1 |
| Riemer, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1/2 Study of Decitabine Alone and/or in Combination With Chemotherapy and/or Cytokine Induced Killer Cell Transfusion in Patients With Relapsed or Refractory Solid Tumors and B Cell Lymphomas[NCT01799083] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2012-12-31 | Recruiting | ||
| Addition of Decitabine to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Phase 2-3, Open-label, Randomised Controlled Trial[NCT02159820] | Phase 2/Phase 3 | 500 participants (Anticipated) | Interventional | 2014-06-30 | Recruiting | ||
| A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer[NCT00887198] | Phase 3 | 1,088 participants (Actual) | Interventional | 2009-04-28 | Completed | ||
| A Randomized Phase II Trial Comparing Biomarker Directed Therapy Versus Clinician's Choice of Enzalutamide or Docetaxel in Patients With Advanced Prostate Cancer Post Abiraterone[NCT04015622] | Phase 2 | 100 participants (Anticipated) | Interventional | 2020-10-07 | Recruiting | ||
| Phase II Study of Octreotide Treatment of Advanced, Recurrent Thymoma[NCT00003283] | Phase 2 | 38 participants (Anticipated) | Interventional | 1998-10-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Overall survival is defined as the time from randomization to date of death from any cause. (NCT00887198)
Timeframe: From randomization (Day 1) up to end of study (Month 60)
| Intervention | Months (Median) |
|---|---|
| Abiraterone Acetate + Prednisone (AAP) | 34.66 |
| Placebo | 30.29 |
The rPFS was defined as the time from randomization to the occurrence of one of the following: 1) a participant was considered to have progressed by bone scan if - a) the first bone scan with greater than or equal to (>=) 2 new lesions compared to baseline was observed in less than (<) 12 weeks from randomization and was confirmed by a second bone scan taken >=6 weeks later showing >=2 additional new lesions (a total of >=4 new lesions compared to baseline), b) the first bone scan with >=2 new lesions compared to baseline was observed in >=12 weeks from randomization and the new lesions were verified on the next bone scan >=6 weeks later (a total of >=2 new lesions compared to baseline); 2) progression of soft tissue lesions measured by computerized tomography (CT) or magnetic resonance imaging (MRI); 3) death from any cause. (NCT00887198)
Timeframe: From randomization (Day 1) up to first radiographic progression or cutoff date (Month 18)
| Intervention | Months (Median) |
|---|---|
| Abiraterone Acetate + Prednisone (AAP) | NA |
| Placebo | 8.28 |
The time interval from the date of randomization to the first date at which there was at least a 1 grade change (worsening) in the ECOG performance status grade. Participants who had no deterioration in ECOG performance status grade at the time of the analysis were censored at the last known date of no deterioration. ECOG is a 5-point scale, where 0=Fully active, 1=Ambulatory, carry out work of sedentary nature, 2=Ambulatory, capable of all self-care, 3=Capable of limited self-care, confined to bed or chair more than 50% of waking hours, 4=Completely disabled, no self-care, totally confined to bed or chair, 5=Dead. Participants with no assessment were censored at the date of randomization. (NCT00887198)
Timeframe: From randomization (Day 1) up to first radiographic progression or cutoff date (Month 18)
| Intervention | Months (Median) |
|---|---|
| Abiraterone Acetate + Prednisone (AAP) | 12.29 |
| Placebo | 10.87 |
The time interval from the date of randomization to the date of initiation of cytotoxic chemotherapy for prostate cancer. Participants who had no cytotoxic chemotherapy administration at the time of analysis were censored at the last known date when no cytotoxic chemotherapy was administered. Participants with no assessment were censored at the date of randomization. (NCT00887198)
Timeframe: From randomization (Day 1) up to initiation of cytotoxic chemotherapy or cutoff date (Month 18)
| Intervention | Months (Median) |
|---|---|
| Abiraterone Acetate + Prednisone (AAP) | 25.17 |
| Placebo | 16.82 |
The time interval from the date of randomization to the date of opiate use for cancer pain. Participants who have no opiate use at the time of analysis were censored at the last known date of no opiate use for cancer pain. Participants with no assessment were censored at the date of randomization. (NCT00887198)
Timeframe: From randomization (Day 1) up to first opiate use or end of study (Month 60)
| Intervention | Months (Median) |
|---|---|
| Abiraterone Acetate + Prednisone (AAP) | 33.38 |
| Placebo | 23.39 |
The time interval from the date of randomization to the date of PSA progression as defined in the protocol-specific prostate cancer Working Group 2 (PCWG2) criteria. A participant was considered to have a PSA progression if the PSA level had a 25 percent (%) or greater increase from nadir and an absolute increase of 2 nanogram/milliliter ((ng/mL) or more, which is confirmed by a second value obtained in 3 or more weeks. Participants who had no PSA progression at the time of the analysis were censored at the last known date of no PSA progression. Participants with no on-study PSA assessment or no baseline PSA assessment were censored at the date of randomization. (NCT00887198)
Timeframe: From randomization (Day 1) up to date of PSA progerssion or cutoff date (Month 18)
| Intervention | Months (Median) |
|---|---|
| Abiraterone Acetate + Prednisone (AAP) | 11.07 |
| Placebo | 5.55 |
An adverse event (AE) was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. A serious adverse event (SAE) was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Treatment-emergent were events between administration of study drug and up to 30 days after last dose of study drug that were absent before treatment or that worsened relative to pre-treatment state. (NCT00887198)
Timeframe: From first dose of study drug up to 30 days after the last dose of study drug
| Intervention | Participants (Number) | |
|---|---|---|
| With Treatment-Emergent Adverse Events | With Treatment-Emergent Serious Adverse Events | |
| Abiraterone Acetate + Prednisone (AAP) | 541 | 208 |
| Placebo | 524 | 148 |
| Placebo to Abiraterone Acetate | 93 | 39 |
9 reviews available for prednisone and Carcinoma
| Article | Year |
|---|---|
Adult abdominal Burkitt lymphoma with isolated peritoneal involvement.
Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carcinoma; Cyclophosphami | 2014 |
Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; C | 2006 |
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cispla | 1984 |
Virilizing adrenal carcinoma in a woman of reproductive age: a case presentation and literature review.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Carcinoma; Female; Hirsutism; Humans; Infertility, F | 1995 |
Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression.
Topics: Actuarial Analysis; Antilymphocyte Serum; Azathioprine; Carcinoma; Cyclosporine; Graft Survival; Her | 1992 |
Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; Carcinoma; C | 1985 |
Combined drug therapy for ovarian carcinoma.
Topics: Antineoplastic Agents; Carcinoma; Cell Division; Cobalt Isotopes; Cytarabine; DNA, Neoplasm; Drug Sy | 1970 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
Ectopic PTH syndrome, pseudohyperparathyroidism; hypercalcaemia of malignancy.
Topics: Adenocarcinoma; Adenoma; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium; Carcinoma; | 1974 |
9 trials available for prednisone and Carcinoma
| Article | Year |
|---|---|
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2014 |
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2014 |
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2014 |
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2014 |
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease Progress | 2011 |
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Pr | 2012 |
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplasti | 2012 |
Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2004 |
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cispla | 1984 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Combined Modality Therapy | 1996 |
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; | 1998 |
Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Small Cell; Carmustine; Cycloph | 1978 |
59 other studies available for prednisone and Carcinoma
| Article | Year |
|---|---|
[Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].
Topics: Androgen Antagonists; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Humans | 2017 |
Case report: metastases from thyroid and nasopharyngeal carcinomas in the same lymph node following chemotherapy for mantle cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Papillary; Cyclophospha | 2015 |
Paraneoplastic Dermatomyositis Accompanying Nasopharyngeal Carcinoma.
Topics: Carcinoma; Dermatomyositis; Dexamethasone; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Naso | 2015 |
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Topics: Abiraterone Acetate; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplas | 2017 |
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Topics: Abiraterone Acetate; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplas | 2017 |
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Topics: Abiraterone Acetate; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplas | 2017 |
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Topics: Abiraterone Acetate; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplas | 2017 |
Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2010 |
Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer.
Topics: Autoantibodies; Carcinoma; Fatal Outcome; Female; Humans; Middle Aged; Ovarian Neoplasms; Phlebitis; | 2010 |
Efficacy of the CMFVP regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemo | 2012 |
[Extranodal follicular dendritic cell sarcoma of neck region: report of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Dendritic Cell Sarcoma, | 2012 |
Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 2002 |
[On the problem of the effect of high doses of prednisone on malignant epithelial tumors].
Topics: Carcinoma; Humans; Prednisone | 1960 |
Treatment of advanced carcinoma of the breast by bilateral oophorectomy and prednisone.
Topics: Breast Neoplasms; Carcinoma; Castration; Female; Humans; Mastectomy; Ovariectomy; Prednisone | 1960 |
Treatment of advanced carcinoma of the breast by oophorectomy and prednisone.
Topics: Breast Neoplasms; Carcinoma; Castration; Female; Humans; Mastectomy; Ovariectomy; Prednisone | 1960 |
HYPERCALCAEMIA IN RENAL CARCINOMA. REPORT OF A CASE.
Topics: Alkaline Phosphatase; Blood; Bone Neoplasms; Calcium; Carcinoma; Carcinoma, Renal Cell; Electrocardi | 1964 |
POLYMYOSITIS ASSOCIATED WITH ACUTE MONOCYTIC LEUKEMIA: CASE REPORT AND REVIEW OF THE LITERATURE.
Topics: Biopsy; Bone Marrow Cells; Carcinoma; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloi | 1964 |
HYPERCALCEMIA OF BREAST CANCER; MANAGEMENT WITH CORTICOSTEROIDS.
Topics: Adrenal Cortex Hormones; Breast Neoplasms; Calcium; Carcinoma; Drug Therapy; Geriatrics; Humans; Hyp | 1965 |
Radiation reaction in the lung. Report of a fatal case in a patient with carcinoma of the lung, with studies of pulmonary function before and during predenisone therapy.
Topics: Carcinoma; Humans; Lung; Lung Neoplasms; Medical Records; Prednisone | 1960 |
The role of estrogen receptor status in predicting the response of carcinoma of the breast to adjuvant chemotherapy.
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Pap | 1982 |
Immune thrombocytopenia associated with carcinoma.
Topics: Adult; Aged; Blood Platelets; Carcinoembryonic Antigen; Carcinoma; Female; Humans; Immunoglobulin G; | 1983 |
[Acute leukemias and solid tumors in the course of Hodgkin disease].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1983 |
Pure red cell aplasia obscured by a diagnosis of carcinoma.
Topics: Aged; Anemia, Aplastic; Bone Marrow Examination; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squa | 1983 |
Compromised CT detection of extracranial malignant neoplasms by steroid treatment.
Topics: Absorptiometry, Photon; Animals; Carcinoma; Male; Muscles; Neoplasm Transplantation; Neoplasms, Expe | 1981 |
Synchronous bilateral carcinoma of the adrenal gland: 2 case reports.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Carcinoma; Female; Fludrocortisone; Humans; Male; Middle A | 1993 |
Distinctive features of idiopathic inflammatory myopathies in French Canadians.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoi | 1996 |
Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P)
Topics: Aged; Anti-Inflammatory Agents; Breast Neoplasms; Bronchoalveolar Lavage Fluid; Carcinoma; Chemother | 1998 |
High grade MALT-lymphoma of the breast.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Cyclophos | 1999 |
Survival of patients with HTLV-I-associated lymph node lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Doxorubicin; Hodgkin Di | 1999 |
Peritoneal sarcoidosis.
Topics: Adult; Ascites; Carcinoma; Diagnosis, Differential; Female; Glucocorticoids; Humans; Mycoses; Perito | 2002 |
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Cyclophosphamide; | 2002 |
Managing ulcerative colitis.
Topics: Azathioprine; Carcinoma; Colitis, Ulcerative; Colonic Neoplasms; Humans; Prednisone; Sulfasalazine | 1976 |
[Confluent pulmonary deposits from carcinoma of the breast under cytostatic therapy (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Female; H | 1976 |
[Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Car | 1976 |
Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined M | 1990 |
Multimodal treatment for inflammatory breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined M | 1989 |
[The effect of chemotherapy on survival time in advanced breast carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carmustine; Combined Mo | 1989 |
Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Dose- | 1989 |
Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Hodgkin | 1988 |
Radiation pneumonitis: a complication resulting from combined radiation and chemotherapy for early breast cancer.
Topics: Breast Neoplasms; Carcinoma; Combined Modality Therapy; Female; Humans; Middle Aged; Pneumonia; Pred | 1985 |
The adrenal glands of elderly men in relation to abnormal prostatic growth. An analysis in an autopsy series.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Medulla; Adult; Aged; Autopsy; Body Height | 1973 |
Management of far-advanced carcinoma of the lung.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Aged; Alkylating Agents; Brain Neoplasms; Carcinoma; Carcin | 1966 |
Treatment of dermatomyositis with methotrexate.
Topics: Adrenal Cortex Hormones; Adult; Aged; Breast Neoplasms; Carcinoma; Dermatomyositis; Female; Humans; | 1968 |
[Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Castration; Cyclophosphamide; Drug Therapy, Comb | 1974 |
[1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; Drug Synergism; F | 1972 |
Disseminated breast carcinoma. Treatment with combination chemotherapy.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma; Cyclophosphamide; Drug Therapy, Combination; Fem | 1973 |
Thymoma associated with pure red cell aplasia and hypogammaglobulinemia.
Topics: Agammaglobulinemia; Aged; Anemia, Aplastic; Blood Cell Count; Blood Transfusion; Bone Marrow Examina | 1973 |
The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Aged; Angiography; Antineoplast | 1974 |
[Carcinoma of the male breast].
Topics: Breast Neoplasms; Carcinoma; False Negative Reactions; Humans; Male; Mastectomy; Middle Aged; Neopla | 1974 |
[Letter: Prednisone treatment of breast cancer with metastases].
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carcinoma; Female; Femoral Neoplasms; Humans; Neoplas | 1974 |
Rh-incompatible platelet transfusions--risks and consequences of sensitizing immunosuppressed patients.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antibodies; Antibody Formation; Blood Group Incompatibili | 1971 |
Chemotherapy in the management of metastatic cancer of unknown primary site.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Chlorambucil; Cyclopho | 1972 |
On the mechanism of action of carbohydrate active steroids on tastant detection and recognition.
Topics: Addison Disease; Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Insufficiency; Ad | 1972 |
[Delayed hypersensitivity reaction to 2,4-dinitrochlorobenzol in cancer patients undergoing cytostatic chemotherapy].
Topics: Age Factors; Aged; Bronchial Neoplasms; Carcinoma; Cyclophosphamide; Drug Antagonism; Fractures, Bon | 1971 |
[Myeloblastic leukemia with a Philadelphia chromosome].
Topics: Aged; Carcinoma; Chromosome Aberrations; Chromosome Disorders; Diploidy; Humans; Karyotyping; Laryng | 1967 |
Autoimmune hemolytic anemia and ulcerative colitis: a multisystem immunodeficiency disease?
Topics: Adolescent; Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Anti-Idiotypic; Blood Cell Count; Bloo | 1970 |
Hypercalcemia associated with neoplastic disease.
Topics: Breast Neoplasms; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Dactinomycin; Electrocar | 1970 |
Metastatic calcification of the myocardium.
Topics: Adult; Autopsy; Breast Neoplasms; Calcinosis; Carcinoma; Cardiomyopathies; Female; Fluoxymesterone; | 1970 |
[Erysipelatoid, angiectasic cancer of the breast. Mode of development].
Topics: Breast Neoplasms; Carcinoma; Cyclophosphamide; Female; Humans; Lymphedema; Middle Aged; Neoplasm Rec | 1967 |
Hepatic failure in the tropics.
Topics: Acute Disease; Adolescent; Adult; Africa; Aged; Carcinoma; Chronic Disease; Diet; Female; Hepatic En | 1968 |
Hormonal therapy of cancer of the female breast.
Topics: Androgens; Breast Neoplasms; Carcinoma; Diethylstilbestrol; Estrogens; Ethinyl Estradiol; Female; Ho | 1969 |
Metastatic carcinoma to the choroid with choroidal detachment. A case presenting as uveal effusion.
Topics: Carcinoma; Choroid; Choroid Neoplasms; Eye Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neop | 1969 |